Gene Therapy for Wiskott-Aldrich Syndrome—Long-Term Efficacy and Genotoxicity

Gene Therapy for Wiskott-Aldrich Syndrome—Long-Term Efficacy and Genotoxicity is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Gene Therapy for Wiskott-Aldrich Syndrome—Long-Term Efficacy and Genotoxicity have?

Gene Therapy for Wiskott-Aldrich Syndrome—Long-Term Efficacy and Genotoxicity has 558 citations in the OpenAlex counts ScholarIQ stores.

When was Gene Therapy for Wiskott-Aldrich Syndrome—Long-Term Efficacy and Genotoxicity published?

Gene Therapy for Wiskott-Aldrich Syndrome—Long-Term Efficacy and Genotoxicity has 2014 year in the ScholarIQ index.

What is the open-access status of Gene Therapy for Wiskott-Aldrich Syndrome—Long-Term Efficacy and Genotoxicity?

Gene Therapy for Wiskott-Aldrich Syndrome—Long-Term Efficacy and Genotoxicity has green oa status in the ScholarIQ index.

What is the DOI of Gene Therapy for Wiskott-Aldrich Syndrome—Long-Term Efficacy and Genotoxicity?

The DOI for Gene Therapy for Wiskott-Aldrich Syndrome—Long-Term Efficacy and Genotoxicity is on the source record.

What is the PMID of Gene Therapy for Wiskott-Aldrich Syndrome—Long-Term Efficacy and Genotoxicity?

The PMID for Gene Therapy for Wiskott-Aldrich Syndrome—Long-Term Efficacy and Genotoxicity is on the source record.

What is the OpenAlex record for Gene Therapy for Wiskott-Aldrich Syndrome—Long-Term Efficacy and Genotoxicity?

The OpenAlex for Gene Therapy for Wiskott-Aldrich Syndrome—Long-Term Efficacy and Genotoxicity is on the source record.